000			01916 a2200541 4500
005			20250516164608.0
264		0	_c20140331
008			201403s 0 0 eng d
022			_a1872-8227
024	7		_a10.1016/S0168-8227(13)70016-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aChraibi, Abdelmjid
245	0	0	_aSafety and effectiveness of insulin analogues in Moroccan patients with type 2 diabetes: a sub-analysis of the A₁chieve study. _h[electronic resource]
260			_bDiabetes research and clinical practice _cAug 2013
300			_aS27-36 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study
650	0	4	_aBiomarkers _xblood
650	0	4	_aBlood Glucose _xmetabolism
650	0	4	_aBlood Pressure
650	0	4	_aDiabetes Mellitus, Type 2 _xblood
650	0	4	_aDrug Therapy, Combination
650	0	4	_aDrug-Related Side Effects and Adverse Reactions _xepidemiology
650	0	4	_aFemale
650	0	4	_aGlycated Hemoglobin _xmetabolism
650	0	4	_aHumans
650	0	4	_aHypoglycemia _xblood
650	0	4	_aHypoglycemic Agents _xadministration & dosage
650	0	4	_aInsulin Aspart _xadministration & dosage
650	0	4	_aInsulin Detemir
650	0	4	_aInsulin, Long-Acting _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMorocco _xepidemiology
650	0	4	_aPostprandial Period
650	0	4	_aPrevalence
650	0	4	_aProspective Studies
650	0	4	_aQuality of Life
650	0	4	_aRisk Factors
650	0	4	_aTreatment Outcome
650	0	4	_aWeight Gain
700	1		_aAjdi, Farida
700	1		_aBelkhadir, Jamal
700	1		_aEl Ansari, Naoual
700	1		_aMarouan, Fatima
700	1		_aFarouqi, Ahmed
773	0		_tDiabetes research and clinical practice _gvol. 101 Suppl 1 _gp. S27-36
856	4	0	_uhttps://doi.org/10.1016/S0168-8227(13)70016-0 _zAvailable from publisher's website
999			_c23016549 _d23016549